OPTIMER PHARMACEUTICALS INC 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Oct 28, 2013
Insider Transaction Report
Form 4
Newman Stephen L
Director
Transactions
- Disposition to Issuer
Common stock
2013-10-24$10.75/sh−7,500$80,625→ 0 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 30, 2013 (the "Merger Agreement"), among Optimer Pharmaceuticals, Inc. ("Optimer"), Cubist Pharmaceuticals, Inc. ("Cubist"), and PDRS Corporation, each award was fully vested and converted into the right to receive per share consideration of: (i) $10.75 cash and (ii) one contingent value right issued by Cubist in accordance with the Contingent Value Rights Agreement, dated as of October 24, 2013, between Cubist and American Stock Transfer & Trust Company, LLC (together, the "Per Share Merger Consideration") with respect to each share of Optimer common stock subject to the award.